Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Comments

Is it time to increase the liposomal doxorubicin dosage for frontline therapy in young adults and adults with classic Hodgkin lymphoma? Comment on: “Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy?”

Department of Clinical Medicine and Surgery, Hematology Unit, Federico II University Medical School, Naples
Department of Clinical Medicine and Surgery, Hematology Unit, Federico II University Medical School, Naples
Haematologica Early view May 7, 2026 https://doi.org/10.3324/haematol.2026.301044

Abstract

Not available.

Figures & Tables

Article Information

Early view : Comments
 
DOI
https://doi.org/10.3324/haematol.2026.301044
 
Published
2026-05-07
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
23
PDF Downloads
22
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online